ABSTRACT
Although, the current treatment of sarcoidosis is discussed elsewhere in this
book, during the last few years, new treatments for sarcoidosis have been introduced (1-3). Many of these newer agents were studied in sarcoidosis
because of their benefits reported in other chronic inflammatory diseases.
The general class of these agents has been called immune-mediated inflam-
matory drugs (4). This classification will be useful for clinicians as they
evaluate these agents (5).
